Wird geladen...

Comparative effectiveness of pembrolizumab vs. nivolumab in patients with recurrent or advanced NSCLC

The efficacies of pembrolizumab and nivolumab have never been directly compared in a real-world study. Therefore, we sought to retrospectively evaluate the objective response rate (ORR) and the progression-free survival (PFS) of patients with recurrent or advanced non-small cell lung cancer (NSCLC)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Rep
Hauptverfasser: Cui, Pengfei, Li, Ruixin, Huang, Ziwei, Wu, Zhaozhen, Tao, Haitao, Zhang, Sujie, Hu, Yi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7403144/
https://ncbi.nlm.nih.gov/pubmed/32753702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-70207-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!